How much does a box of ritexitinib capsules cost in the country?

The drug ritexitinib is already available in the domestic market, but it has not yet been included in my country's medical insurance system. This means that patients who need this drug must bear the full cost themselves, which undoubtedly increases the financial burden on patients. It is understood that the latest selling price of this drug in China is approximately 3,200 yuan, which is a considerable expense for many patients.

However, there is a relatively economical option—the Lucius version of the generic drug that is officially marketed in Laos. The ingredients of this generic drug are basically the same as those of the original drug ritexitinib, but the price is more affordable. The latest price is about 2000 yuan. Although it is not an original drug, its high similarity in ingredients makes it an alternative choice for many patients.

The pharmacological effect of ritixitinib is very significant. It is a highly selective inhibitor of tyrosine kinases expressed in the Januskinase3 (JAK 3) and hepatocellular carcinoma (TEC) kinase families. This high selectivity makes it excellent in treating certain diseases. In June 2023, the U.S. Food and Drug Administration (FDA) officially approved ritixitinib for the treatment of severe alopecia areata in adults and adolescents aged 12 years and older. This approval undoubtedly brings new treatment options to patients and further proves the important status of ritexitinib in the pharmaceutical field.

Although ritexitinib is not currently included in medical insurance and patients need to purchase it at their own expense, its unique pharmacological effects and broad therapeutic application prospects make it still attract the attention and choice of many patients.